Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) Equity Average (2021 - 2025)

Biote has reported Equity Average over the past 5 years, most recently at -$62.0 million for Q4 2025.

  • Quarterly results put Equity Average at -$62.0 million for Q4 2025, up 46.72% from a year ago — trailing twelve months through Dec 2025 was -$62.0 million (up 46.72% YoY), and the annual figure for FY2025 was -$82.2 million, down 15.44%.
  • Equity Average for Q4 2025 was -$62.0 million at Biote, up from -$72.2 million in the prior quarter.
  • Over the last five years, Equity Average for BTMD hit a ceiling of $7.4 million in Q1 2022 and a floor of -$134.1 million in Q3 2024.
  • Median Equity Average over the past 5 years was -$64.6 million (2022), compared with a mean of -$59.0 million.
  • Biggest five-year swings in Equity Average: plummeted 4758.04% in 2022 and later surged 46.72% in 2025.
  • Biote's Equity Average stood at $1.4 million in 2021, then plummeted by 4758.04% to -$64.6 million in 2022, then soared by 31.99% to -$43.9 million in 2023, then tumbled by 165.06% to -$116.4 million in 2024, then surged by 46.72% to -$62.0 million in 2025.
  • The last three reported values for Equity Average were -$62.0 million (Q4 2025), -$72.2 million (Q3 2025), and -$81.8 million (Q2 2025) per Business Quant data.